Establishment of Human cell Type-Specific iPS cells with Enhanced Chondrogenic Potential

Stem Cell Reviews and Reports

Volumn 10, Issue 6, 2014, Pages 820-829

  Guzzo, Rosa M ^a   Scanlon, Vanessa ^a   Sanjay, Archana ^a   Xu, Ren He ^a,b   Drissi, Hicham ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b University of Macau   (Macao)

Author keywords

Articular cartilage; Chondrogenic differentiation; Cord blood; Human induced pluripotent stem cells; Reprogramming

Indexed keywords

CARTILAGE; CARTILAGE CELL; CELL DIFFERENTIATION; CELL LINE; CHONDROGENESIS; FETUS BLOOD; FIBROBLAST; HUMAN; MONONUCLEAR CELL; PHYSIOLOGY; PLURIPOTENT STEM CELL;

CARTILAGE; CELL DIFFERENTIATION; CELL LINE; CHONDROCYTES; CHONDROGENESIS; FETAL BLOOD; FIBROBLASTS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; LEUKOCYTES, MONONUCLEAR;

EID: 84930384055     PISSN: 26293269     EISSN: 26293277     Source Type: Journal    
DOI: 10.1007/s12015-014-9538-8     Document Type: Article

References (34)

1. Nakayama N. & Umeda K. (2011) From Pluripotent Stem Cells to Lineage-Specific Chondrocytes: Essential Signaling and Cellular Intermediates. Embryonic Stem Cells: The Hormonal Regulation of Pluripotency and Embryogenesis, ed Atwood C (InTech).
2. Robinton, D. A., & Daley, G. Q. (2012). The promise of induced pluripotent stem cells in research and therapy. Nature, 481, 295–305.
3. Wu, S. M., & Hochedlinger, K. (2011). Harnessing the potential of induced pluripotent stem cells for regenerative medicine. Nature Cell Biology, 13, 497–505.
4. Long, F., & Ornitz, D. M. (2013). Development of the endochondral skeleton. Cold Spring Harbor Perspectives in Biology, 5, a008334.
5. Lefebvre, V., & Smits, P. (2005). Transcriptional control of chondrocyte fate and differentiation. Birth Defects Research. Part C, Embryo Today, 75(3), 200–212.
6. Wuelling, M., & Vortkamp, A. (2010). Transcriptional networks controlling chondrocyte proliferation and differentiation during endochondral ossification. Pediatric Nephrology (Berlin, Germany), 25, 625–631.
7. Guzzo, R. M., Gibson, J., Xu, R. H., Lee, F. Y., & Drissi, H. (2013). Efficient differentiation of human iPSC-derived mesenchymal stem cells to chondroprogenitor cells. Journal of Cellular Biochemistry, 114, 480–490.
8. Toh, W. S., Lee, E. H., Richards, M., & Cao, T. (2010). In vitro derivation of chondrogenic cells from human embryonic stem cells. Methods in Molecular Biology, 584, 317–331.
9. Craft, A. M., Ahmed, N., Rockel, J. S., et al. (2013). Specification of chondrocytes and cartilage tissues from embryonic stem cells. Development (Cambridge, England), 140, 2597–2610.
10. Oldershaw, R. A., Baxter, M. A., Lowe, E. T., et al. (2010). Directed differentiation of human embryonic stem cells toward chondrocytes. Nature Biotechnology, 28, 1187–1194.
11. Diekman, B. O., Christoforou, N., Willard, V. P., et al. (2012). Cartilage tissue engineering using differentiated and purified induced pluripotent stem cells. Proceedings of the National Academy of Sciences of the United States of America, 109, 19172–19177.
12. Onyekwelu, I., Goldring, M. B., & Hidaka, C. (2009). Chondrogenesis, joint formation, and articular cartilage regeneration. Journal of Cellular Biochemistry, 107, 383–392.
13. Koyama, N., Miura, M., Nakao, K., et al. (2013). Human induced pluripotent stem cells differentiated into chondrogenic lineage via generation of mesenchymal progenitor cells. Stem Cells and Development, 22, 102–113.
14. Liu, Y., Goldberg, A. J., Dennis, J. E., Gronowicz, G. A., & Kuhn, L. T. (2012). One-step derivation of mesenchymal stem cell (MSC)-like cells from human pluripotent stem cells on a fibrillar collagen coating. PLoS One, 7(3), e33225.
15. Abyzov, A., Mariani, J., Palejev, D., et al. (2012). Somatic copy number mosaicism in human skin revealed by induced pluripotent stem cells. Nature, 492, 438–442.
16. Zhang, X. B. (2013). Cellular reprogramming of human peripheral blood cells. Genomics, Proteomics & Bioinformatics, 11, 264–274.
17. Meng, X., Neises, A., Su, R. J., et al. (2009). Efficient reprogramming of human cord blood CD34+ cells into induced pluripotent stem cells with OCT4 and SOX2 alone. Molecular Therapy, 20, 408–416.
18. Haase, A., Olmer, R., Schwanke, K., et al. (2009). Generation of induced pluripotent stem cells from human cord blood. Cell Stem Cell, 5, 434–441.
19. Bar-Nur, O., Russ, H. A., Efrat, S., & Benvenisty, N. (2011). Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet Beta cells. Cell Stem Cell, 9, 17–23.
20. Kim, K., Doi, A., Wen, B., et al. (2010). Epigenetic memory in induced pluripotent stem cells. Nature, 467, 285–290.
21. Kim, K., Zhao, R., Doi, A., et al. (2011). Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells. Nature Biotechnology, 29, 1117–1119.
22. Polo, J. M., Liu, S., Figueroa, M. E., et al. (2010). Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nature Biotechnology, 28, 848–855.
23. Sullivan, G. J., Bai, Y., Fletcher, J., & Wilmut, I. (2010). Induced pluripotent stem cells: epigenetic memories and practical implications. Molecular Human Reproduction, 16, 880–885.
24. Ohi, Y., Qin, H., Hong, C., et al. (2011). Incomplete DNA methylation underlies a transcriptional memory of somatic cells in human iPS cells. Nature Cell Biology, 13, 541–549.
25. Xu, H., Yi, B. A., Wu, H., et al. (2011). Highly efficient derivation of ventricular cardiomyocytes from induced pluripotent stem cells with a distinct epigenetic signature. Cell Research, 22, 142–154.
26. Shao, K., Koch, C., Gupta, M. K., et al. (2012). Induced pluripotent mesenchymal stromal cell clones retain donor-derived differences in DNA methylation profiles. Molecular Therapy, 21, 240–250.
27. Rizzi, R., Di Pasquale, E., Portararo, P., et al. (2012). Post-natal cardiomyocytes can generate iPS cells with an enhanced capacity toward cardiomyogenic re-differentation. Cell Death and Differentiation, 19, 1162–1174.
28. Pfaff, N., Lachmann, N., Kohlscheen, S., et al. (2012). Efficient hematopoietic redifferentiation of induced pluripotent stem cells derived from primitive murine bone marrow cells. Stem Cells and Development, 21, 689–701.
29. Ghosh, Z., Wilson, K. D., Wu, Y., Hu, S., Quertermous, T., & Wu, J. C. (2010). Persistent donor cell gene expression among human induced pluripotent stem cells contributes to differences with human embryonic stem cells. PLoS One, 5, e8975.
30. Lee, S. B., Seo, D., Choi, D., et al. (2012). Contribution of hepatic lineage stage-specific donor memory to the differential potential of induced mouse pluripotent stem cells. Stem Cells, 30, 997–1007.
31. Sommer, C. A., Stadtfeld, M., Murphy, G. J., Hochedlinger, K., Kotton, D. N., & Mostoslavsky, G. (2009). Induced pluripotent stem cell generation using a single lentiviral stem cell cassette. Stem Cells, 27, 543–549.
32. Martins-Taylor, K., Nisler, B. S., Taapken, S. M., et al. (2011). Recurrent copy number variations in human induced pluripotent stem cells. Nature Biotechnology, 29, 488–491.
33. Muller, F. J., Schuldt, B. M., Williams, R., et al. (2011). A bioinformatic assay for pluripotency in human cells. Nature Methods, 8, 315–317.
34. Muller F.J., Brandl B., Loring J.F. (2008) Assessment of human pluripotent stem cells with PluriTest. In: StemBook. Cambridge, MA; 2008.